plantmad
biopharmaceut
long
consid
promis
technolog
provid
inexpens
efficaci
medicin
develop
countri
well
combat
pandem
infecti
diseas
use
person
medicin
plant
viru
express
vector
produc
high
level
pharmaceut
protein
within
short
time
period
recent
plant
virus
employ
nanoparticl
novel
form
cancer
treatment
review
provid
glimps
develop
plant
viru
express
system
pharmaceut
product
well
immunotherapi
plantderiv
biopharmaceut
includ
vaccin
monoclon
antibodi
therapeut
protein
rapidli
emerg
marketplac
today
commerci
plantmad
pharmaceut
product
offer
protalix
bio
therapeut
inc
karmiel
israel
planet
biotechnolog
inc
hayward
ca
usa
icon
genet
gmbh
hall
germani
biolog
deriv
plant
demonstr
effect
safe
inexpens
easi
gener
en
mass
store
ambient
temperatur
attribut
make
plantderiv
biopharmaceut
attract
altern
provid
medicin
previous
inaccess
poor
develop
countri
longstand
goal
yet
realiz
plantderiv
vaccin
pharmaceut
found
addit
applic
exampl
plantmad
vaccin
stockpil
measur
protect
global
pandem
biolog
warfar
threat
use
provid
person
medicin
rapid
turnaround
afford
implement
first
plantderiv
pharmaceut
gener
transgen
plant
length
gener
time
protein
express
level
two
princip
caveat
technolog
approach
respons
transient
express
use
plant
viru
express
vector
becam
attract
venu
biopharmaceut
could
also
gener
viru
vectorbas
express
system
could
simultan
shorten
product
time
increas
pharmaceut
yield
remov
concern
gener
public
use
genet
modifi
organ
gmo
recent
plant
virus
found
nich
field
cancer
immunotherapi
act
nanoparticl
home
elicit
form
highli
local
immun
respons
solid
tumor
plant
viru
nanoparticl
even
engin
carri
drug
payload
cancer
cell
thu
offer
new
potent
arsen
cancer
research
physician
alik
histori
develop
plant
viru
express
vector
biopharmaceut
develop
becom
power
tool
review
aim
describ
viru
express
system
current
use
explor
recent
applic
product
system
nanoparticl
cancer
immunotherapi
rigid
rodshap
tobamovirus
includ
tobacco
mosaic
viru
tmv
tmv
copi
capsid
protein
cp
first
viru
engin
deconstruct
vector
system
new
express
system
compos
two
modul
one
contain
replicas
portion
genom
respons
viral
replic
contain
site
foreign
gene
express
tmv
use
express
full
length
protein
epitop
form
fusion
protein
exampl
includ
nori
et
al
huang
anoth
exampl
tmv
undergon
extens
develop
fraunhof
usa
potenti
vaccin
pandem
influenza
viru
clinic
trial
current
underway
other
also
examin
paramet
tmvbase
influenza
vaccin
develop
exampl
matsuda
et
al
found
temperatur
post
viral
vector
inocul
influenc
spatial
express
hemagglutinin
ha
content
nicotiana
benthamiana
leav
author
determin
c
optim
temperatur
requir
obtain
maxim
stabl
yield
ha
similarli
patil
et
al
shown
light
intens
affect
movement
viral
gene
product
liu
kearney
develop
tobamoviru
infect
legum
base
sun
hemp
mosaic
viru
shmv
incorpor
attribut
strategi
develop
icon
trbo
vector
shec
vector
lack
cp
thu
form
virion
also
replic
poorli
absenc
silenc
suppressor
tobamovirusbas
system
regul
vaccin
product
highli
induc
contain
condit
recent
discoveri
adjuv
properti
tmv
spark
renew
interest
use
viru
deliveri
vehicl
immunotherapi
tmv
particl
demonstr
taken
dendrit
cell
exhibit
activ
properti
result
robust
cell
respons
banik
et
al
use
tmv
particl
act
adjuv
epitop
display
system
vaccin
develop
facult
intracellular
pathogen
francisella
tularensi
elicit
advers
reaction
administ
mice
yet
protect
respiratori
challeng
high
dose
f
tularensi
live
vaccin
strain
lv
similarli
jone
et
al
use
virusbas
deliveri
platform
mean
gener
malaria
transmiss
block
vaccin
tbv
specif
target
protein
express
mosquito
midgut
plasmodium
falciparum
develop
tbv
protein
protein
could
potenti
target
reduc
transmiss
malaria
tmv
deconstruct
vector
also
use
produc
hpv
vaccin
base
vlp
compos
protein
vaccin
could
offer
safe
inexpens
vaccin
poor
develop
countri
magnicon
deconstruct
vector
perhap
wellknown
use
effort
develop
person
medicin
nonhodgkin
lymphoma
nhl
nhl
cancer
overprolifer
b
cell
estim
new
case
alon
sinc
malign
b
cell
present
uniqu
cell
surfac
idiotyp
specif
individu
patient
vaccin
use
idiotyp
tmv
construct
compos
scfv
subunit
fulllength
idiotyp
igg
molecul
express
deconstruct
magnicon
vector
heavi
light
chain
assembl
full
immunoglobulin
plant
vaccin
construct
success
pass
phase
clinic
trial
demonstr
safe
elicit
advers
effect
number
patient
mount
immun
respons
compar
result
earlier
clinic
trial
use
follicular
lymphoma
idiotyp
vaccin
gener
use
product
platform
furthermor
vaccin
manufactur
extrem
rapid
take
less
three
month
obtain
complet
vaccin
base
upon
us
fda
cgmp
guidanc
initi
biopsi
inform
requir
larg
scale
product
pharmaceut
protein
use
magnicon
system
pleas
refer
klimyuk
et
al
tobacco
mosaic
viru
engin
tumorspecif
use
tumor
home
peptid
crgd
function
surfac
viru
tmv
particl
display
crgd
becom
rapidli
intern
tumor
cell
doxorubicin
anticanc
drug
also
conjug
tmv
taken
cancer
cell
releas
endocytosi
potato
viru
x
pvx
flexuou
rodshap
viru
contain
plussens
rna
molecul
also
engin
extens
express
vector
biopharmaceut
genom
pvx
consist
replicas
capsid
protein
gene
well
tripl
gene
block
whose
product
respons
viru
movement
pvx
use
express
fulllength
protein
fusion
protein
epitop
display
outer
surfac
assembl
viru
particl
recent
pvx
nanoparticl
demonstr
block
tumor
progress
anim
model
exampl
pvxbase
express
system
engin
produc
n
protein
sudden
acquir
respiratori
syndrom
coronaviru
sarscov
antigen
plantderiv
n
protein
use
examin
presenc
nspecif
antibodi
sera
patient
expos
coronaviru
pvx
employ
develop
univers
influenza
vaccin
consist
epitop
deriv
extracellular
domain
viru
matrix
protein
research
fuse
bacteri
flagellin
strong
mucos
adjuv
order
improv
immunogen
n
benthamiana
plant
infect
pvx
vector
express
fusion
protein
abl
produc
mgg
fresh
leaf
tissu
total
solubl
protein
inocul
mice
protect
influenza
infect
pvx
produc
antigen
well
exampl
uhdeholzem
et
al
use
pvx
express
epitop
hepat
c
viru
hcv
fusion
protein
mice
immun
parenter
elicit
igg
respons
sera
chronic
infect
hcv
patient
react
posit
epitop
similarli
mohammadzadeh
et
al
fuse
epitop
hcv
core
antigen
hepat
b
viru
surfac
antigen
hbsag
express
result
chimer
construct
second
coat
protein
promot
pvx
vector
papaya
mosaic
potexviru
papmv
use
express
epitop
envelop
protein
hcv
gener
long
last
humor
antibodi
respons
mice
papmv
also
employ
carrier
potenti
univers
flu
vaccin
fuse
epitop
outer
surfac
papmv
nanoparticl
recent
pvx
design
act
nanoparticl
tumor
immunotherapi
pvx
nanofila
carri
monoclon
antibodi
herceptin
trastuzumab
breast
cancer
patient
could
induc
apoptosi
breast
cancer
cell
line
pvx
express
mutant
version
oncoprotein
part
fusion
protein
lichenas
protect
mice
tumor
growth
gener
strong
cytotox
tcell
respons
extern
lysin
residu
capsid
protein
pvx
function
take
conjug
shukla
et
al
found
pvx
accumul
center
solid
tumor
suggest
pvx
use
tissuespecif
imag
drug
deliveri
papmv
also
immunostimulatori
properti
act
nanoparticl
papmv
nanoparticl
elicit
respons
administ
intratumor
slow
melanoma
progress
prolong
surviv
anim
model
papmv
undergo
rapid
endocytosi
antigenpres
cell
result
cell
prolifer
mice
treat
system
papmv
nanoparticl
follow
cell
six
hour
later
exhibit
fewer
tumor
nodul
compar
control
mice
fact
result
could
reproduc
capsid
monom
nake
viru
rna
indic
assembl
nanoparticl
requir
immun
protect
comoviru
cowpea
mosaic
viru
cpmv
undergon
extens
develop
express
vector
cpmv
icosahedr
viru
nm
diamet
compris
larg
l
small
capsid
protein
genom
cpmv
bipartit
princip
compon
express
vector
develop
cpmv
util
extens
antigen
present
fulllength
protein
express
part
fusion
protein
undergo
proteolyt
cleavag
releas
therapeut
protein
well
materi
scienc
research
format
magnet
cluster
biosensor
exampl
medicago
inc
durham
nc
usa
use
cpmv
vector
gener
viruslik
particl
vlp
carri
influenza
viru
ha
antigen
vlp
protect
lethal
viral
challeng
anim
model
undergo
phase
clinic
trial
volunt
medicago
cpmv
product
system
enabl
vaccin
gener
within
week
releas
influenza
strain
sequenc
inform
easili
adapt
upscal
capac
cpmv
deconstruct
vector
system
peaq
involv
express
foreign
protein
without
need
viral
replic
thu
reliev
cell
hindranc
creat
viral
cycl
progress
neg
impact
protein
accumul
involv
posit
foreign
gene
leader
sequenc
untransl
region
utr
well
delet
infram
initi
codon
found
upstream
main
translat
initi
site
result
vector
provid
substanti
increas
foreign
protein
product
new
vector
known
pcpmvht
cowpea
mosaic
viru
hypertran
express
system
engin
also
provid
high
translat
effici
vector
use
gener
vaccin
bluetongu
viru
hiv
dengu
influenza
viru
cpmv
particl
also
found
bind
vimentin
display
surfac
hela
cell
abl
taken
endocytosi
fact
cpmv
intern
antigenpres
cell
enabl
prime
antibodi
respons
cpmv
nanoparticl
thu
shown
directli
stimul
immun
system
combat
variou
cancer
cpmv
capsid
protein
driven
selfassembl
absenc
rna
form
empti
noninfecti
viruslik
particl
evlp
turn
directli
appli
tumor
alter
surround
microenviron
potenti
tumor
immun
activ
quiescent
neutrophil
neighbor
region
sinc
immun
respons
highli
local
patient
advers
respons
minim
exampl
lizott
et
al
use
mous
model
demonstr
cpmv
nanoparticl
could
act
effect
immunotherapi
lung
melanoma
cancer
capabl
induc
innat
immun
cellmedi
antitumor
respons
author
also
abl
increas
proinflammatori
cytokin
level
provid
cpmv
nanoparticl
bone
marrow
cell
cultur
weekli
inject
cpmv
nanoparticl
reduc
tumor
burden
colon
tumor
well
ovarian
breast
cancer
futur
cpmv
could
carri
anticanc
drug
payload
improv
abil
reduc
tumor
cowpea
mosaic
viru
express
vector
peaght
also
use
express
extracellular
domain
rat
tobacco
plant
epiderm
growth
factorrel
protein
aberr
express
lead
varieti
cancer
plant
extract
express
inject
mice
elicit
immun
respons
potent
antitumour
activ
one
possibl
direct
vector
develop
may
includ
merg
genet
element
two
vastli
differ
viru
express
system
next
section
describ
two
system
first
exampl
mardanova
et
al
util
express
vector
construct
base
pvx
along
translat
enhanc
rna
alfalfa
mosaic
viru
amv
combin
cpmvbase
peaqht
vector
backbon
drive
suppressor
gene
silenc
creat
new
vector
express
system
peff
peff
smaller
size
use
express
candid
influenza
vaccin
protein
fuse
hbc
form
viruslik
particl
level
sever
time
higher
either
pvx
cpmvbase
vector
system
produc
alon
second
exampl
tmv
use
express
genom
alphaviru
flock
hous
viru
fhv
small
insect
viru
replic
high
level
plant
without
induc
apoptosi
includ
origin
assembl
ori
tmv
flock
hous
viru
genom
pseudoviru
consist
fhv
genom
encapsid
tmv
coat
protein
gener
sinc
tmv
behav
like
adjuv
stimul
immun
respons
pseudoviru
approach
use
produc
novel
vaccin
plant
geminivirus
twin
capsid
morpholog
singlestrand
circular
dna
virus
capabl
undergo
replic
broad
rang
host
plant
high
copi
number
result
geminivirus
suitabl
develop
express
vector
geminiviru
bean
yellow
dwarf
viru
beymv
engin
produc
efficaci
monoclon
antibodi
ebola
zika
west
nile
virus
respect
edward
rybicki
group
south
africa
util
beydv
express
construct
contain
hpv
capsid
protein
along
secret
embryon
alkalin
phosphatas
seap
report
construct
assembl
encapsid
hpv
pseudovirion
psv
tobacco
plant
geminiviru
vector
base
beet
curli
top
viru
bctv
use
gener
vaccin
hepat
anoth
exampl
dualmodul
inplant
activ
inpact
express
platform
develop
tobacco
yellow
dwarf
viru
tydv
control
foreign
gene
express
interrupt
express
cassett
plant
intron
protein
interest
express
posttranscript
process
thu
offer
control
express
gene
interest
fundament
difficulti
remain
popul
remot
impoverish
region
access
vaccin
biopharmaceut
protein
includ
high
cost
limit
access
prevent
mani
achiev
better
health
result
better
livelihood
famili
plantmad
vaccin
could
slow
spread
infecti
diseas
major
killer
hiv
hbv
malaria
plant
possess
advantag
express
system
harbor
mammalian
pathogen
certain
instanc
undergo
similar
posttransl
modif
mammalian
counterpart
pharmaceut
deriv
plant
easili
purifi
specif
case
mere
partial
purifi
prior
oral
administr
plantmad
biopharmaceut
fight
cancer
increas
number
plantmad
vaccin
combat
oncogen
virus
concern
resourc
poor
countri
hepat
b
hepat
c
human
papillomaviru
develop
could
make
huge
impact
qualiti
life
hundr
million
peopl
gener
monoclon
antibodi
combat
cancer
varieti
plant
could
also
assist
develop
countri
recent
discoveri
plant
viru
nanoparticl
target
penetr
solid
tumor
particularli
interest
plant
viru
nanoparticl
drug
function
surfac
would
efficaci
low
cost
easi
produc
en
mass
low
toxic
ideal
qualiti
resourcepoor
set
plant
viru
particl
also
platform
technolog
develop
nation
util
grow
pharmaceut
industri
equip
poor
countri
viru
construct
freedom
oper
plantmad
pharmaceut
industri
could
becom
realiti
improv
manufactur
infrastructur
financi
support
matur
regulatori
framework
surround
plantderiv
pharmaceut
essenti
commerci
develop
world
obstacl
overcom
would
seem
mani
exampl
present
review
could
play
signific
role
improv
live
mani
